Federal contractor · MORRISVILLE, NC
INHALON BIOPHARMA, INC.
No contract obligations recorded for INHALON BIOPHARMA, INC. in FY2026. Since FY2024: $5.4M.
- Obligations · FY2026
- $0
- New awards
- 0
- Sole-source
- —
- Single offer
- —
- UEI
- HFQSJ2GMNRU6
Spending by fiscal year
Obligations per federal fiscal year (October–September).
- 2.2MFY2024
- 3.2MFY2025
Top buying agencies
Obligations in FY2026.
No contract obligations recorded for INHALON BIOPHARMA, INC. in FY2026.
What was bought · Where the work was performed
Obligations in FY2026.
What was bought
Where the work was performed
Integrity signals
Shares of the year's obligations, next to the country's.
Exclusions in SAM.gov
Records of the SAM.gov exclusions list (parties debarred, suspended, proposed for debarment or otherwise excluded) matched to this recipient by its Unique Entity ID or CAGE code.
This section could not be loaded right now. Reload the page to try again.
Federal grants & assistance received
Grants, loans (counted at their subsidy cost), direct payments and insurance, by fiscal year of the action (USAspending.gov, FABS). Reported apart from contracts and never added to them.
This section could not be loaded right now. Reload the page to try again.
Subawards
Matched by Unique Entity ID: the first-tier subawards this organization reported as a prime recipient, and those primes reported paying it.
This section could not be loaded right now. Reload the page to try again.
Competitors
Companies that win from the same buyers in the same markets: obligations by agency and industry compared over the last three fiscal years.
Compared on 1 market (agency × industry), FY2024–FY2026.
- TAO TREASURES, LLC$5.8M−88% in FY2026FREDERICK, MD · 100% of this company's obligations are in markets they both serveDefense Health Agency · Scientific research and development services
- AUBURN, AL · 90% of this company's obligations are in markets they both serveDefense Health Agency · Scientific research and development services
- BAKINAW-SCITECH JOINT VENTURE CORPORATION$4.6M−27% in FY2026MOUNT PLEASANT, MI · 84% of this company's obligations are in markets they both serveDefense Health Agency · Scientific research and development services
Showing the top 3 of 25 competitors. Open the profile for the full list.
Who sells to the same buyers in the same markets, not who wins against whom on a given contract. Prime contract obligations by the agency and NAICS code of each award; subawards are never added. A company is a family of legal entities, joined by parent UEI or, in part, by an AI reading of names.
Source: Federal contract transactions (Federal Procurement Data System) (U.S. Department of the Treasury, USAspending.gov), data current to Oct 9, 2026, loaded Oct 9, 2026 · FY2024–FY2026.
Lobbying and PAC activity
Organizations in House lobbying disclosures and FEC records whose names an AI judgment matched to this company. Those records carry no identifier shared with contracts, so every match is by name.
This section could not be loaded right now. Reload the page to try again.
Source: Federal contract transactions (Federal Procurement Data System) (U.S. Department of the Treasury, USAspending.gov), data current to Oct 9, 2026, loaded Oct 9, 2026.